NICOX (EPA:COX) | WebDisclosure

BRIEF

published on 12/16/2025 at 07:35, 1 day 20 hours ago

Nicox finalise les données clés de la soumission de la NDA du NCX 470 d'ici le premier semestre 2026

Essais Cliniques Ophtalmologie Nicox NCX 470 Soumission D'un Accord De Confidentialité
BRIEF

published on 12/16/2025 at 07:35, 1 day 20 hours ago

Nicox Finalizes Key Data for NCX 470 NDA Submission by H1 2026

Clinical Trials Ophthalmology Nicox NCX 470 NDA Submission
PRESS RELEASE

published on 12/16/2025 at 07:30, 1 day 20 hours ago

Nicox finalise la génération des données clés de demande d’autorisation de mise sur le marché de NCX 470 pour un dépôt maintenu au premier semestre 2026
Nicox finalise la génération des données clés pour la demande d’autorisation de mise sur le marché de NCX 470, dépôt maintenu au premier semestre 2026. Réunions pré-NDA avec la FDA américaine et dépôt NDA en Chine également en bonne voie

FDA Autorisation De Mise Sur Le Marché Nicox NCX 470 Dépôt NDA
PRESS RELEASE

published on 12/16/2025 at 07:30, 1 day 20 hours ago

Nicox Completes NCX 470 New Drug Application Key Data Generation for Submission as Planned in H1 2026
Nicox completes key data generation for NCX 470 new drug application submission in H1 2026, including clinical trial and stability data. U.S. and China submissions on track

FDA Clinical Trials Nicox NCX 470 New Drug Application
BRIEF

published on 10/23/2025 at 07:35, 1 month 25 days ago

Nicox Releases First Half 2025 Financial Results

Financial Results Debt Repayment Ophthalmology Cost Control NCX 470
BRIEF

published on 10/23/2025 at 07:35, 1 month 25 days ago

Nicox publie ses résultats financiers du premier semestre 2025

Résultats Financiers Ophtalmologie Remboursement De La Dette Contrôle Des Coûts NCX 470
PRESS RELEASE

published on 10/23/2025 at 07:30, 1 month 25 days ago

Nicox Provides First Half 2025 Financial Results
Nicox provides first half 2025 financial results, expects NDA submissions for NCX 470 in 2026. Company aims to finance operations for 12 months and repay debts by 2026

Financial Results Debt Repayment Nicox NCX 470 NDA Submissions
BRIEF

published on 10/02/2025 at 07:35, 2 months 15 days ago

Nicox : Résultats positifs pour NCX 470 dans l'étude Denali

Essai Clinique Ophtalmologie Nicox NCX 470 Pression Intraoculaire
BRIEF

published on 10/02/2025 at 07:35, 2 months 15 days ago

Nicox: Positive results for NCX 470 in the Denali study

Clinical Trial Ophthalmology Nicox NCX 470 Intraocular Pressure
PRESS RELEASE

published on 10/02/2025 at 07:30, 2 months 15 days ago

Nicox annonce que NCX 470 a démontré une efficacité soutenue jusqu’à 12 mois dans l’essai clinique Denali, sans effets indésirables nouveaux observés
Nicox annonce que NCX 470 a démontré une efficacité soutenue jusqu’à 12 mois dans l’essai clinique Denali, sans effets indésirables nouveaux observés. Les analyses préplanifiées confirment un profil similaire à Mont Blanc

Étude Clinique Ophtalmologie Nicox NCX 470 Denali

Published on 12/18/2025 at 00:55, 3 hours 3 minutes ago

Molten Metals Corp. Announces Flow-Through Financing
Published on 12/18/2025 at 00:00, 3 hours 58 minutes ago

Right Season Investments Announces Name Change to FutureGen Industries Corp.
Published on 12/17/2025 at 23:15, 4 hours 43 minutes ago

Northern Superior Announces the Ratio for the Distribution of the Common Shares in the Capital of ONGold Resources Ltd.
Published on 12/17/2025 at 15:00, 12 hours 58 minutes ago

BlackBerry Unveils Ground-Up Modernization of BlackBerry AtHoc Mobile Experience to Enable More Intelligent Operations
Published on 12/17/2025 at 14:00, 13 hours 58 minutes ago

UniDoc Completes H3 Health Cube Installation in Italy

View all ACCESSWIRE

Published on 12/18/2025 at 01:10, 2 hours 48 minutes ago

Samsung To Unveil New AI-Connected Living Lineup at CES 2026
Published on 12/18/2025 at 00:50, 3 hours 8 minutes ago

Historic production of graphene enhanced cement successfully completed
Published on 12/17/2025 at 22:05, 5 hours 53 minutes ago

Abivax annonce l’acceptation de 22 abstracts sur obefazimod dans les MICI à l’ECCO 2026, dont une présentation orale sur des résultats précliniques antifibrotiques
Published on 12/17/2025 at 22:05, 5 hours 53 minutes ago

Abivax Announces Acceptance of 22 Abstracts Evaluating Obefazimod in Inflammatory Bowel Disease at ECCO 2026, Featuring an Oral Presentation on Preclinical Anti-Fibrotic Findings
Published on 12/17/2025 at 21:22, 6 hours 36 minutes ago

EQS-Adhoc: DATAGROUP SE: DATAGROUP SE Management Board plans dividend of EUR 0.04 per share

View all EQS

Published on 12/17/2025 at 20:39, 7 hours 19 minutes ago

Aeroports de Paris SA | 2026 Airport charges in Paris
Published on 12/17/2025 at 20:39, 7 hours 19 minutes ago

Aeroports de Paris SA | Tarifs des redevances aeroportuaires 2026 à Paris
Published on 12/17/2025 at 19:30, 8 hours 28 minutes ago

Change in the composition of the Board
Published on 12/17/2025 at 19:30, 8 hours 28 minutes ago

Evolution de la composition du Conseil d’Administration
Published on 12/17/2025 at 18:00, 9 hours 58 minutes ago

Outstanding Shares and Voting Rights Statement at 30 November 2025

View all LES ECHOS COMFI WIRE

News